Research
Early research indicates grey flu is entering non-lethal mutation, says Xia-Hifa head of viral studies
Xia-Hifa Biologics and Pandora Haze Technologies to jointly fund new bionic limb study
New synthetic skin developed by Xia-Hifa approved for human trials
PRESS
"Haemorrhaging Data: How Scientists Raced to Contain Junin 2" by Alejandra Cruz wins Pulitzer
Arenovir patents projected to raise Xia-Hifa valuation by 42%
X-H3 granted Fast Track Status by MHRA
Hyperpath wins Business Monthly award
Xia-Hifa in talks with UK government for tax exempt status
A year since the Junin 2 epidemic, we talk to Alex Zedong, CEO of Xia-Hifa Biologics
Community
New health initiative: how Xia-Hifa can help you secure your future
Xia-Hifa expands funding in local communities